How to go about securing the best return for your investment in Canada.
Latest News
TFSA contribution room calculator Jan 1st
Find out your current tax-free savings account (TFSA) contribution limit by using this calculator.
powered by
Tax-free savings account is a bit of a misnomer. While you can use it for straightforward savings, think of it more accurately as an investment holding account to store things like&nb.... More »
Regulators issue warning on binary options scams + MORE Mar 3rd
Canadian regulators are raising the alarm with an awareness campaign about investor fraud involving so-called “binary option” scams.
Options are a popular but sophisticated product that can be used by experienced investors as part of an investment strategy, often providing offsetting positions t.... More »
Why “unretirement” may be the fate of so many Canadians Mar 13th
The idea of “unretirement” seems to be making a comeback as more Canadians find themselves under economic stress. Even before the tariff threats emerged under Trump 2.0, seniors and near-retirees were finding the economic uncertainty and rising cost of living becoming uncomfortable. No surprise .... More »
Calendar: What investors need to know for the week ahead Dec 23rd
A daily rundown of the economic reports and corporate earnings that will be grabbing the market's attention in the week ahead
.... More »
Former CP head Harrison on track for CSX leadership, sources say + MORE Jan 23rd
Hard-nosed operator known for squeezing assets, slashing costs and boosting stock prices is reportedly eyeing the soon-to-be vacant position, and analysts say there’s no other obvious choice
.... More »
WL Ross buying chemicals and plastics distributor Nexeo
– canadianbusiness.com
NEW YORK, N.Y. – WL Ross Holdings Corp., a company formed to make acquisitions, will buy control of the chemicals and plastics distribution company Nexeo Solutions Holdings LLC for about $1.6 billion.
WL Ross, run by billionaire investor Wilbur Ross, said it is buying the company from the global asset manager TPG, which will retain a 35 per cent stake. WL Ross will then change its name to Nexeo Solutions Inc.
Under the deal, WL Ross will buy the company for about 35 million shares of its common stock, along with about $1.3 million in cash and will assume It will also assume debt.
Nexeo, which is based in The Woodlands, Texas, had revenue of about $3.9 billion in its most recent fiscal year and operates in more than 80 countries with more than 2,450 employees, according to New York City-based WL Ross.
Following completion of the deal, Ross will serve as chairman of the company while current Nexeo CEO David Bradley will continue as the company’s leader.
The deal is expected to close in the second quarter…
WL Ross, run by billionaire investor Wilbur Ross, said it is buying the company from the global asset manager TPG, which will retain a 35 per cent stake. WL Ross will then change its name to Nexeo Solutions Inc.
Under the deal, WL Ross will buy the company for about 35 million shares of its common stock, along with about $1.3 million in cash and will assume It will also assume debt.
Nexeo, which is based in The Woodlands, Texas, had revenue of about $3.9 billion in its most recent fiscal year and operates in more than 80 countries with more than 2,450 employees, according to New York City-based WL Ross.
Following completion of the deal, Ross will serve as chairman of the company while current Nexeo CEO David Bradley will continue as the company’s leader.
The deal is expected to close in the second quarter…
CEO of embattled Quebec drugmaker Valeant Pharmaceuticals leaving
– canadianbusiness.com
LAVAL, Que. – The CEO of embattled Valeant Pharmaceuticals is leaving.
The Quebec-based drug company says J. Michael Pearson will remain as CEO and president until a successor is named.
Valeant was once one of Canada’s most valuable companies, but in recent months it has been beset by a number of controversies.
The company is facing allegations of drug-price gouging, accusations it has denied.
It is also under investigation by the U.S. Securities and Exchange Commission, U.S. Attorney’s offices in Massachusetts and New York, as well as Congress, as part of their probes into price hikes for certain drugs.
Last Tuesday, Valeant saw its shares lose more than $15 billion of their value after reporting disappointing earnings, lowering its outlook for 2016 and raising fears about defaulting on its debt.
“It’s been a privilege to lead Valeant for the past eight years,” Pearson said in a statement Monday.
“While I regret the controversies that have adversely impacted our business over the past several months, I know that Valeant is a strong and resilient company, and I am committed to doing everything I can to ensure a smooth transition to new leadership…
The Quebec-based drug company says J. Michael Pearson will remain as CEO and president until a successor is named.
Valeant was once one of Canada’s most valuable companies, but in recent months it has been beset by a number of controversies.
The company is facing allegations of drug-price gouging, accusations it has denied.
It is also under investigation by the U.S. Securities and Exchange Commission, U.S. Attorney’s offices in Massachusetts and New York, as well as Congress, as part of their probes into price hikes for certain drugs.
Last Tuesday, Valeant saw its shares lose more than $15 billion of their value after reporting disappointing earnings, lowering its outlook for 2016 and raising fears about defaulting on its debt.
“It’s been a privilege to lead Valeant for the past eight years,” Pearson said in a statement Monday.
“While I regret the controversies that have adversely impacted our business over the past several months, I know that Valeant is a strong and resilient company, and I am committed to doing everything I can to ensure a smooth transition to new leadership…
Sheraton-owner Starwood accepts higher offer from Marriott
– theglobeandmail.com
New stock-and-cash offer is worth $13.6-billion, and trumps an all-cash offer from China’s Anbang Insurance Group, worth $13.16-billion.
WASHINGTON – A U.S. judge is urging the Obama administration to protect from public disclosure federal court records related to the once-secret criminal history of a former Donald Trump business partner.
In a highly unusual order prompted by The Associated Press, U.S. District Judge Brian M. Cogan said that unless the Justice Department acts before April 18, he will decide whether to make the court files public under the assumption that federal prosecutors don’t care.
The case involves Felix Sater, a Trump business associate who had pleaded guilty in a major Mafia-linked stock fraud scheme and co-operated with the government. The AP reported in December that, even after learning about Sater’s background, Trump tapped Sater for a business development role in 2010 that included the title of senior adviser to Trump. Sater received Trump Organization business cards and was given an office within the Trump Organization’s headquarters, on the same floor as Trump’s own…
In a highly unusual order prompted by The Associated Press, U.S. District Judge Brian M. Cogan said that unless the Justice Department acts before April 18, he will decide whether to make the court files public under the assumption that federal prosecutors don’t care.
The case involves Felix Sater, a Trump business associate who had pleaded guilty in a major Mafia-linked stock fraud scheme and co-operated with the government. The AP reported in December that, even after learning about Sater’s background, Trump tapped Sater for a business development role in 2010 that included the title of senior adviser to Trump. Sater received Trump Organization business cards and was given an office within the Trump Organization’s headquarters, on the same floor as Trump’s own…
Valeant Pharmaceuticals International looks for new CEO, Bill Ackman to join board – Financial Post
– news.google.ca
Financial PostValeant Pharmaceuticals International looks for new CEO, Bill Ackman to join boardFinancial PostBloomberg/Associated PressValeant Pharmaceuticals International Inc. Chief Executive Officer Mike Pearson, left, will step down, Former Chief Financial Officer Howard Schiller, centre, has been asked to resign and investor Bill Ackman will join the board.Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial …StockhouseIs Concordia Healthcare Corp. or Valeant Pharmaceuticals Intl Inc. the Better Buy?The Motley Fool CanadaCEO of Quebec's embattled Valeant Pharmaceuticals stepping downToronto StarFinancial Times -bnn.ca -CBC.ca -StreetInsider.comall 297 news articles »
